LifeStance Health (LFST) Cash from Investing Activities (2020 - 2025)
LifeStance Health (LFST) has disclosed Cash from Investing Activities for 6 consecutive years, with -$10.9 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities fell 73.16% to -$10.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.1 million through Dec 2025, down 67.51% year-over-year, with the annual reading at -$36.1 million for FY2025, 67.51% down from the prior year.
- Cash from Investing Activities for Q4 2025 was -$10.9 million at LifeStance Health, down from -$10.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$5.1 million in Q3 2024, with the low at -$79.6 million in Q4 2021.
- Average Cash from Investing Activities over 5 years is -$19.4 million, with a median of -$11.2 million recorded in 2023.
- The sharpest move saw Cash from Investing Activities crashed 329.7% in 2022, then surged 81.47% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$79.6 million in 2021, then surged by 61.92% to -$30.3 million in 2022, then soared by 62.33% to -$11.4 million in 2023, then surged by 44.8% to -$6.3 million in 2024, then plummeted by 73.16% to -$10.9 million in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$10.9 million, -$10.3 million, and -$7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.